Literature DB >> 15815725

Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.

Y Guo1, K Karube, R Kawano, T Yamaguchi, J Suzumiya, G-S Huang, K Ohshima.   

Abstract

Follicular lymphomas (FL) are morphologically classified into grades 1, 2, 3a and 3b by the World Health Organization. Bcl2, Bcl6 and CD10 are phenotypic markers of FL while the Bcl2 t(14;18) and Bcl6 t(3q27) gene translocations are common genetic changes. However, to date, there has been no integrated analysis based on phenotype, grade and genotype from large numbers of FL cases. We graded 261 cases of FL and determined their phenotypes and gene alterations. According to the antigen markers and gene alterations of 147 cases, we classified FL into typical and the others types. The typical group, which includes 69% cases of FL, is characterized by low histological grade (grade 1, 2), coexpression of BCL2 and CD10 and Bcl2 gene translocation. The rest comprises a small part of low-grade FL without Bcl2 gene translocation and high-grade (grade 3a, 3b) FL. These FLs include some heterogeneous disease entities. They are characterized by high histological grade (87%), no definite expression of BCL2 or CD10 and several kinds of gene aberrances including Bcl2 translocation, Bcl6 translocation, Bcl2 amplification or other unknown gene abnormality. Our findings indicate that typical FL presents a homogeneous disease entity whereas the rest comprises heterogeneous diseases entities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15815725     DOI: 10.1038/sj.leu.2403738

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

1.  Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Authors:  Ana Borovecki; Petra Korać; Marin Nola; Davor Ivanković; Branimir Jaksić; Mara Dominis
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

2.  Follicular lymphoma grade 3B: is it a real disease?

Authors:  Nancy Lee Harris; Philip Kluin
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

Review 3.  Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.

Authors:  Jianfeng Li; Yuting Dai; Liang Wu; Ming Zhang; Wen Ouyang; Jinyan Huang; Saijuan Chen
Journal:  Front Med       Date:  2021-01-05       Impact factor: 4.592

4.  ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.

Authors:  Olga K Weinberg; Weiyun Z Ai; M Rajan Mariappan; Carol Shum; Ronald Levy; Daniel A Arber
Journal:  J Mol Diagn       Date:  2007-07-25       Impact factor: 5.568

5.  Follicular lymphoma of the thyroid gland.

Authors:  Chris M Bacon; Timothy C Diss; Hongtao Ye; Hongxiang Liu; Alison Goatly; Rifat Hamoudi; Andrew Wotherspoon; Randy D Gascoyne; Ahmet Dogan; Ming-Qing Du; Peter G Isaacson
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

6.  Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study.

Authors:  Cindy M Chang; Jane C Schroeder; Wen-Yi Huang; Cherie H Dunphy; Ralph S Baric; Andrew F Olshan; Kathleen C Dorsey; Georgette A Dent; James R Cerhan; Charles F Lynch; Nathaniel Rothman; Kenneth P Cantor; Aaron Blair
Journal:  Leuk Res       Date:  2009-06-07       Impact factor: 3.156

7.  Analysis of follicular lymphoma by dual-color fluorescence in situ hybridization.

Authors:  Dakeun Lee; Jinwon Seo; YoungLyun Oh; Jinman Kim; YoungHyeh Ko
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

8.  Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.

Authors:  E Klyuchnikov; U Bacher; K Woo Ahn; J Carreras; N M Kröger; P N Hari; G H Ku; E Ayala; A I Chen; Y-B Chen; J B Cohen; C O Freytes; R P Gale; R T Kamble; M A Kharfan-Dabaja; H M Lazarus; R Martino; A Mussetti; B N Savani; H C Schouten; S Z Usmani; P H Wiernik; B Wirk; S M Smith; A Sureda; M Hamadani
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

9.  Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification.

Authors:  Reiji Muto; Hiroaki Miyoshi; Kensaku Sato; Takuya Furuta; Hiroko Muta; Keisuke Kawamoto; Eriko Yanagida; Kyohei Yamada; Koichi Ohshima
Journal:  Cancer Med       Date:  2018-10-11       Impact factor: 4.452

10.  CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine.

Authors:  Nobuhiko Ohnishi; Katsuyoshi Takata; Tomoko Miyata-Takata; Yasuharu Sato; Akira Tari; Yuka Gion; Mai Noujima-Harada; Kohei Taniguchi; Tetsuya Tabata; Keina Nagakita; Shizuma Omote; Hiroyuki Takahata; Masaya Iwamuro; Hiroyuki Okada; Yoshinobu Maeda; Hiroyuki Yanai; Tadashi Yoshino
Journal:  Cancer Sci       Date:  2016-10-14       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.